Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7).
Spinocerebellar ataxia 7 (SCA7) is caused by the expansion of an unstable CAG repeat in the first exon of the SCA7 gene. We have analyzed the SCA7 mutation in 19 families and one isolated case of various geographical origins, presenting with autosomal dominant cerebellar ataxia with progressive macular dystrophy. The SCA7 CAG repeat was expanded in 77 patients and in 11 at-risk individuals, with alleles containing from 37 to 130 repeats, demonstrating that SCA7 is genetically homogeneous. Repeats on normal alleles contained from 7 to 35 CAGs. There was a strong negative correlation (r = -0.84) between the age at onset and the size of the CAG repeat expansion in SCA7 patients. Larger expansions were associated with earlier onset, a more severe and rapid clinical course, and a higher frequency of decreased vision, ophthalmoplegia, extensor plantar response and scoliosis. The frequency of other clinical signs such as dysphagia and sphincter disturbances increased with disease duration. The mutation was highly unstable during transmission, with a mean increase of 10 +/- 16 CAG repeats, which was significantly greater in paternal (15 +/- 20) than in maternal (5 +/- 5) transmissions. This correlated well with the marked anticipation (19 +/- 13 years) observed in the families. Gonadal mosaicism, observed in the sperm of a patient, was particularly important, with expanded alleles ranging from 42 to >155 CAG repeats. The degree of instability during transmission, resulting mostly in expansions, is greater than in the seven other neurodegenerative disorders caused by polyglutamine expansions.
David
G
G
INSERM U289 and Fédération de Neurologie, Hôpital de la Salpêtrière, 47 bd. de l'Hôpital, 75651 Paris Cedex 13, France.
Dürr
A
A
Stevanin
G
G
Cancel
G
G
Abbas
N
N
Benomar
A
A
Belal
S
S
Lebre
A S
AS
Abada-Bendib
M
M
Grid
D
D
Holmberg
M
M
Yahyaoui
M
M
Hentati
F
F
Chkili
T
T
Agid
Y
Y
Brice
A
A
D000293:Adolescent; D000328:Adult; D000352:Africa, Northern / Q000453:epidemiology; D017668:Age of Onset; D000368:Aged; D000483:Alleles; D001530:Belgium / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D002893:Chromosomes, Human, Pair 3 / Q000235:genetics*; D003680:Deglutition Disorders / Q000453:epidemiology / Q000235:genetics; D005091:Exons / Q000235:genetics; D005242:Fecal Incontinence / Q000453:epidemiology / Q000235:genetics; D005260:Female; D005602:France / Q000453:epidemiology; D005799:Genes, Dominant; D006801:Humans; D007223:Infant; D007557:Israel / Q000453:epidemiology; D008268:Macular Degeneration / Q000453:epidemiology / Q000235:genetics*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009030:Mosaicism; D009849:Olivopontocerebellar Atrophies / Q000453:epidemiology / Q000235:genetics / Q000473:pathology; D009886:Ophthalmoplegia / Q000453:epidemiology / Q000235:genetics; D012600:Scoliosis / Q000453:epidemiology / Q000235:genetics; D012720:Severity of Illness Index; D013094:Spermatozoa / Q000737:chemistry; D013132:Spinocerebellar Degenerations / Q000145:classification / Q000453:epidemiology / Q000235:genetics*; D013577:Syndrome; D018911:Trinucleotide Repeats; D014549:Urinary Incontinence / Q000453:epidemiology / Q000235:genetics